niraparib and Erythema-Multiforme

niraparib has been researched along with Erythema-Multiforme* in 1 studies

Other Studies

1 other study(ies) available for niraparib and Erythema-Multiforme

ArticleYear
Switching PARP inhibitors as an effective approach for niraparib-induced erythema multiforme.
    International journal of dermatology, 2022, Volume: 61, Issue:10

    Topics: Erythema Multiforme; Humans; Indazoles; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors

2022